Cargando…
EP1276: USTEKINUMAB HAS COMPARABLE LONG-TERM EFFECTIVENESS AS ANTI-TNF AGENTS IN BIOLOGIC-NAÏVE PATIENTS WITH CROHN'S DISEASE
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AGA Institute. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212507/ http://dx.doi.org/10.1016/S0016-5085(22)62599-X |
| _version_ | 1784730612456751104 |
|---|---|
| author | Shiga, Hisashi Moroi, Rintaro Makuuchi, Motoki Takahashi, Takahiro Shimoyama, Yusuke Kuroha, Masatake Kakuta, Yoichi Kinouchi, Yoshitaka Masamune, Atsushi |
| author_facet | Shiga, Hisashi Moroi, Rintaro Makuuchi, Motoki Takahashi, Takahiro Shimoyama, Yusuke Kuroha, Masatake Kakuta, Yoichi Kinouchi, Yoshitaka Masamune, Atsushi |
| author_sort | Shiga, Hisashi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9212507 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AGA Institute. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92125072022-06-22 EP1276: USTEKINUMAB HAS COMPARABLE LONG-TERM EFFECTIVENESS AS ANTI-TNF AGENTS IN BIOLOGIC-NAÏVE PATIENTS WITH CROHN'S DISEASE Shiga, Hisashi Moroi, Rintaro Makuuchi, Motoki Takahashi, Takahiro Shimoyama, Yusuke Kuroha, Masatake Kakuta, Yoichi Kinouchi, Yoshitaka Masamune, Atsushi Gastroenterology AGA Abstracts AGA Institute. Published by Elsevier Inc. 2022-05 2022-06-16 /pmc/articles/PMC9212507/ http://dx.doi.org/10.1016/S0016-5085(22)62599-X Text en Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | AGA Abstracts Shiga, Hisashi Moroi, Rintaro Makuuchi, Motoki Takahashi, Takahiro Shimoyama, Yusuke Kuroha, Masatake Kakuta, Yoichi Kinouchi, Yoshitaka Masamune, Atsushi EP1276: USTEKINUMAB HAS COMPARABLE LONG-TERM EFFECTIVENESS AS ANTI-TNF AGENTS IN BIOLOGIC-NAÏVE PATIENTS WITH CROHN'S DISEASE |
| title | EP1276: USTEKINUMAB HAS COMPARABLE LONG-TERM EFFECTIVENESS AS ANTI-TNF AGENTS IN BIOLOGIC-NAÏVE PATIENTS WITH CROHN'S DISEASE |
| title_full | EP1276: USTEKINUMAB HAS COMPARABLE LONG-TERM EFFECTIVENESS AS ANTI-TNF AGENTS IN BIOLOGIC-NAÏVE PATIENTS WITH CROHN'S DISEASE |
| title_fullStr | EP1276: USTEKINUMAB HAS COMPARABLE LONG-TERM EFFECTIVENESS AS ANTI-TNF AGENTS IN BIOLOGIC-NAÏVE PATIENTS WITH CROHN'S DISEASE |
| title_full_unstemmed | EP1276: USTEKINUMAB HAS COMPARABLE LONG-TERM EFFECTIVENESS AS ANTI-TNF AGENTS IN BIOLOGIC-NAÏVE PATIENTS WITH CROHN'S DISEASE |
| title_short | EP1276: USTEKINUMAB HAS COMPARABLE LONG-TERM EFFECTIVENESS AS ANTI-TNF AGENTS IN BIOLOGIC-NAÏVE PATIENTS WITH CROHN'S DISEASE |
| title_sort | ep1276: ustekinumab has comparable long-term effectiveness as anti-tnf agents in biologic-naïve patients with crohn's disease |
| topic | AGA Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212507/ http://dx.doi.org/10.1016/S0016-5085(22)62599-X |
| work_keys_str_mv | AT shigahisashi ep1276ustekinumabhascomparablelongtermeffectivenessasantitnfagentsinbiologicnaivepatientswithcrohnsdisease AT moroirintaro ep1276ustekinumabhascomparablelongtermeffectivenessasantitnfagentsinbiologicnaivepatientswithcrohnsdisease AT makuuchimotoki ep1276ustekinumabhascomparablelongtermeffectivenessasantitnfagentsinbiologicnaivepatientswithcrohnsdisease AT takahashitakahiro ep1276ustekinumabhascomparablelongtermeffectivenessasantitnfagentsinbiologicnaivepatientswithcrohnsdisease AT shimoyamayusuke ep1276ustekinumabhascomparablelongtermeffectivenessasantitnfagentsinbiologicnaivepatientswithcrohnsdisease AT kurohamasatake ep1276ustekinumabhascomparablelongtermeffectivenessasantitnfagentsinbiologicnaivepatientswithcrohnsdisease AT kakutayoichi ep1276ustekinumabhascomparablelongtermeffectivenessasantitnfagentsinbiologicnaivepatientswithcrohnsdisease AT kinouchiyoshitaka ep1276ustekinumabhascomparablelongtermeffectivenessasantitnfagentsinbiologicnaivepatientswithcrohnsdisease AT masamuneatsushi ep1276ustekinumabhascomparablelongtermeffectivenessasantitnfagentsinbiologicnaivepatientswithcrohnsdisease |